Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

Medicine, Cardiology, Hematology +17

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

The EPILOG Investigators · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

New England Journal of Medicine · 1998 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

T Epistent Investigators · The Lancet · 1998 · 1.4K citations

Medicine, Cardiology, Pharmacotherapy +14

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study

The Lancet · 1997 · 1.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +16